ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles
T Li, G Sun, H Ye, C Song, Y Shen, Y Cheng… - British Journal of …, 2024 - nature.com
Background Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with no
clinically ideal biomarkers for early diagnosis. The objective of this study was to develop and …
clinically ideal biomarkers for early diagnosis. The objective of this study was to develop and …
Rapid multiplex immunohistochemistry for characterizing tumor-immune microenvironment
A Kimura, T Tsujikawa, H Morimoto, S Saburi… - Heliyon, 2024 - cell.com
Intratumoral immune profiles are related to prognosis and therapeutic efficacy, and could
result in personalized treatments based on biomarkers. To develop a multiplex, quantitative …
result in personalized treatments based on biomarkers. To develop a multiplex, quantitative …
[HTML][HTML] Pan-cancer proteogenomics characterization of tumor immunity
Despite the successes of immunotherapy in cancer treatment over recent decades, less
than< 10%–20% cancer cases have demonstrated durable responses from immune …
than< 10%–20% cancer cases have demonstrated durable responses from immune …